In patients with T2DM, GLP-1 secretion is reduced and the activity of its receptor signaling path-way is diminished, resulting in insufficient stimulation of insulin secretion and progressive decline of β-cell function [111,112]. The gene discussed is INS; the disease is type 2 diabetes mellitus.